Analysis of phosphate West Gulliver Ding combined with metformin in the treatment of type 2 diabetes mellitus
LI Xiaoton
Abstract
LI Xiaoton
Abstract
Objective To analyze sitagliptin phosphate with metformin treatment of type 2 diabetes. Methods 60 patients with type2 diabetes were randomly divided into experimental and control groups, the control group patients were treated with metformin,sitagliptin phosphate patients in the experimental group therapy on the basis of the control group. Comparison of the two groups of patients. Treatment observation group than the control group, the difference was statistically significant(P0.05). Conclusions Sitagliptin phosphate with metformin treatment of type 2 diabetes significant effect, complication rate, worthy of clinical application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To analyze sitagliptin phosphate with metformin treatment of type 2 diabetes. Methods 60 patients with type2 diabetes were randomly divided into experimental and control groups, the control group patients were treated with metformin,sitagliptin phosphate patients in the experimental group therapy on the basis of the control group. Comparison of the two groups of patients. Treatment observation group than the control group, the difference was statistically significant(P0.05). Conclusions Sitagliptin phosphate with metformin treatment of type 2 diabetes significant effect, complication rate, worthy of clinical application.
Key concepts: Metformin, Sitagliptin, Sitagliptin Phosphate, Medicine, Diabetes mellitus, Type 2 diabetes, Internal medicine, Phosphate